1. Home
  2. RXST vs HPS Comparison

RXST vs HPS Comparison

Compare RXST & HPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RXST
  • HPS
  • Stock Information
  • Founded
  • RXST 1997
  • HPS 2003
  • Country
  • RXST United States
  • HPS United States
  • Employees
  • RXST N/A
  • HPS N/A
  • Industry
  • RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • HPS Investment Managers
  • Sector
  • RXST Health Care
  • HPS Finance
  • Exchange
  • RXST Nasdaq
  • HPS Nasdaq
  • Market Cap
  • RXST 553.1M
  • HPS 450.7M
  • IPO Year
  • RXST 2021
  • HPS N/A
  • Fundamental
  • Price
  • RXST $8.03
  • HPS $14.17
  • Analyst Decision
  • RXST Hold
  • HPS
  • Analyst Count
  • RXST 11
  • HPS 0
  • Target Price
  • RXST $19.40
  • HPS N/A
  • AVG Volume (30 Days)
  • RXST 1.7M
  • HPS 58.4K
  • Earning Date
  • RXST 08-07-2025
  • HPS 01-01-0001
  • Dividend Yield
  • RXST N/A
  • HPS 8.62%
  • EPS Growth
  • RXST N/A
  • HPS N/A
  • EPS
  • RXST N/A
  • HPS N/A
  • Revenue
  • RXST $148,310,000.00
  • HPS N/A
  • Revenue This Year
  • RXST $22.16
  • HPS N/A
  • Revenue Next Year
  • RXST $20.91
  • HPS N/A
  • P/E Ratio
  • RXST N/A
  • HPS N/A
  • Revenue Growth
  • RXST 46.70
  • HPS N/A
  • 52 Week Low
  • RXST $6.32
  • HPS $11.79
  • 52 Week High
  • RXST $58.23
  • HPS $15.40
  • Technical
  • Relative Strength Index (RSI)
  • RXST 21.66
  • HPS 54.67
  • Support Level
  • RXST $6.32
  • HPS $14.32
  • Resistance Level
  • RXST $8.50
  • HPS $14.43
  • Average True Range (ATR)
  • RXST 0.77
  • HPS 0.13
  • MACD
  • RXST -0.52
  • HPS 0.03
  • Stochastic Oscillator
  • RXST 21.50
  • HPS 69.26

About RXST RxSight Inc.

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.

About HPS John Hancock Preferred Income Fund III Preferred Income Fund III

John Hancock Preferred Income Fund III is a closed-end, diversified management investment company. Its investment objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve the objectives by investing a majority of its assets in preferred stocks and other preferred securities, including convertible preferred securities. The portfolio composition of the company consists of the U.S. preferred securities, foreign preferred securities, common stocks, corporate bonds, and the short-term investments.

Share on Social Networks: